Results 21 to 30 of about 9,214 (193)

Dextromethorphan Abuse Among Adolescents [PDF]

open access: yes, 2012
Dextromethorphan abuse has been increasing among adolescents over the past several years. This medication is readily available and socially accepted among peers.
Dunham, Lisa Ann
core   +3 more sources

Dextromethorphan withdrawal and dependence syndrome [PDF]

open access: yes, 2010
Background: The N-methyl-D-aspartate (NMDA) antagonist dextromethorphan has been available in pharmacies without a prescription since 1954 as an antitussive agent. There is an alarming increase in reports of its abuse.
Martin Grosshans   +11 more
core   +1 more source

Enhanced biological degradation of Dextromethorphan and real pharmaceutical wastewater followed by reverse osmosis membrane [PDF]

open access: yesResearch Journal of Applied Biotechnology, 2018
Biological degradation of pharmaceutical wastewater followed by reverse osmosis (RO) membrane technology was investigated. The Membrane separation of Dextromethorphan was performed in a continuous mode operation.
Ayman Sawan   +4 more
doaj   +1 more source

Knowledge, attitude, and the practice of community pharmacists to dispense opioid-related and opioid-containing medication in Eastern Province, Saudi Arabia

open access: yesJournal of Pharmacy and Bioallied Sciences, 2023
Objectives: This study was done to evaluate the knowledge of community pharmacists—working in Saudi Arabia—regarding over-the-counter opioid-related and opioid-containing medications.
Mohammad D Ali   +7 more
doaj   +1 more source

Effect of N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Opioid Analgesia in Pediatric Intensive Care Unit

open access: yesPain Research and Management, 2016
Objective. Pain control is an essential goal in the management of critical children. Narcotics are the mainstay for pain control. Patients frequently need escalating doses of narcotics.
Mohammed Naeem   +3 more
doaj   +1 more source

Dextromethorphan Dampens Neonatal Astrocyte Activation and Endoplasmic Reticulum Stress Induced by Prenatal Exposure to Buprenorphine

open access: yesBehavioural Neurology, 2021
Prenatal exposure to buprenorphine renders offspring vulnerable to cerebral impairments. In this study, our data demonstrate, for the first time, that prenatal exposure to buprenorphine escalates astrocyte activation concurrent with indications of ...
Chun-Hua Lin   +6 more
doaj   +1 more source

The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via σ 1 receptor activation: Comparison with the effects of dextromethorphan

open access: yes, 2020
In a previous study, we demonstrated that a dextromethorphan analog, dimemorfan, has neuroprotective effects. Dextromethorphan and dimemorfan are high-affinity ligands at σ 1 receptors.
김원기
core   +1 more source

Dextromethorphan in the treatment of early myoclonic encephalopathy evolving into migrating partial seizures in infancy

open access: yes, 2014
Epileptic encephalopathy with suppression-burst in electroencephalography (EEG) can evolve into a few types of epileptic syndromes. We present here an unusual case of early myoclonic encephalopathy that evolved into migrating partial seizures in infancy.
Chien, Yin-Hsuan;Lin, Ming-I;Weng, Wen-Chin;Du, Jung-Chieh;Lee, Wang-Tso   +1 more
core   +1 more source

Effect of a single dose of dextromethorphan on psychomotor performance and working memory capacity

open access: yesIndian Journal of Psychological Medicine, 2012
Background: Previous studies show that the prolonged use of dextromethorphan produces cognitive deterioration in humans. Aim: The aim of this study was to investigate the effect of a single dose of dextroemthrophan on psychomotor performance and working ...
Hayder M Al-Kuraishy   +2 more
doaj   +1 more source

Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid

open access: yesResearch in Pharmaceutical Sciences, 2023
Background and purpose: Lysosomal-targeted drug delivery can open a new strategy for drug therapy. However, there is currently no universally accepted simulated or artificial lysosomal fluid utilized in the pharmaceutical industry or recognized by the ...
Malaz Yousef   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy